TYROSINE PHOSPHORYLATION AS A MARKER FOR ABERRANTLY REGULATED GROWTH-PROMOTING PATHWAYS IN CELL-LINES DERIVED FROM HEAD AND NECK MALIGNANCIES

被引:120
作者
CARDINALI, M
PIETRASZKIEWICZ, H
ENSLEY, JF
ROBBINS, KC
机构
[1] NIDR,CELLULAR DEV & ONCOL LAB,BETHESDA,MD 20892
[2] WAYNE STATE UNIV,HARPER HOSP,DEPT INTERNAL MED,DIV HEMATOL & ONCOL,DETROIT,MI 48201
关键词
D O I
10.1002/ijc.2910610117
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have utilized a broad approach to address whether tyrosine kinases and the growth pathways they regulate might be functionally aberrant in squamous cell carcinomas (SCC) of the upper aerodigestive tract. This strategy involved assaying for evidence of tyrosine kinase action in lysates of cell lines representing SCC. Our findings revealed a spectrum of elevated tyrosine phosphorylation in SCC lines ranging from less than 2-fold to more than 10-fold above that of control human epidermal keratinocytes. Thus the ability to regulate growth and other pathways controlled by tyrosine phosphorylation was impaired in all the 19 lines examined. Assessment of the receptor for epidermal growth factor (EGF) revealed that its activity was elevated above normal in 14 of the 19 cell lines examined, suggesting that at least a portion of the increased tyrosine phosphorylation observed could be attributed to excessive EGF receptor activity. Our findings provide functional evidence that growth pathways are aberrantly regulated in cell lines representing SCC of the upper aerodigestive tract. (C) 1995 Wiley-Liss, Inc.*
引用
收藏
页码:98 / 103
页数:6
相关论文
共 25 条
  • [1] BOLEN JB, 1993, ONCOGENE, V8, P2025
  • [2] SURAMIN, AN EXPERIMENTAL CHEMOTHERAPEUTIC DRUG, ACTIVATES THE RECEPTOR FOR EPIDERMAL GROWTH-FACTOR AND PROMOTES GROWTH OF CERTAIN MALIGNANT-CELLS
    CARDINALI, M
    SARTOR, O
    ROBBINS, KC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) : 1242 - 1247
  • [3] CARPENTER G, 1978, NATURE, V276, P409, DOI 10.1038/276409a0
  • [4] CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.bi.56.070187.004313
  • [5] COOPER GM, 1990, ONCOGENES
  • [6] THE PHYSIOLOGY OF TRANSFORMING GROWTH-FACTOR-ALPHA
    DERYNCK, R
    [J]. ADVANCES IN CANCER RESEARCH, 1992, 58 : 27 - 52
  • [7] DERYNCK R, 1987, CANCER RES, V47, P707
  • [8] OVEREXPRESSION OF THE HUMAN EGF RECEPTOR CONFERS AN EGF-DEPENDENT TRANSFORMED PHENOTYPE TO NIH 3T3 CELLS
    DIFIORE, PP
    PIERCE, JH
    FLEMING, TP
    HAZAN, R
    ULLRICH, A
    KING, CR
    SCHLESSINGER, J
    AARONSON, SA
    [J]. CELL, 1987, 51 (06) : 1063 - 1070
  • [9] NERVE GROWTH-FACTOR RECEPTORS ON HUMAN MELANOMA CELLS IN CULTURE
    FABRICANT, RN
    DELARCO, JE
    TODARO, GJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (02) : 565 - 569
  • [10] A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS
    FEARON, ER
    VOGELSTEIN, B
    [J]. CELL, 1990, 61 (05) : 759 - 767